Genscript Biotech Corporation

GenScript Biotech Corporation, headquartered in China, operates in the Research and Development Services sector. For 2025, GenScript Biotech's Scope 1 emissions were approximately 19,520,210 kg CO2e, Scope 2 market-based emissions were about 128,855,000 kg CO2e, and Scope 3 emissions were approximately 424,238,710 kg CO2e. This data was reported in a document available through HKEXnews.

The company has set ambitious climate commitments validated by the Science Based Targets initiative (SBTi). GenScript Biotech Corporation commits to reaching net-zero greenhouse gas emissions across its entire value chain by 2050.

Near-term targets include a 54.6% absolute reduction in Scope 1 and 2 GHG emissions by 2033, from a 2023 base year. Additionally, the company aims to reduce absolute Scope 3 GHG emissions from fuel and energy-related activities and waste generated in operations by 32.5% within the same timeframe. GenScript Biotech Corporation also commits that 83% of its suppliers, by emissions covering purchased goods and services, capital goods, and upstream transportation and distribution, will have science-based targets by 2029.

Long-term targets include a 90% absolute reduction in Scope 1 and 2 GHG emissions by 2050 from a 2023 base year, alongside a 90% absolute reduction in Scope 3 GHG emissions within the same timeframe.